RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
RT @DrLiMengYAN1: Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From…
Links of 3 ADE-issue papers above: 1. From JP https://t.co/vtFQ5r9zI8 With my analysis https://t.co/BSLf4VGtEb 2. From China https://t.co/7ybPTCvIcn 3. From US https://t.co/nCQ1CbJb4c
@r_rigatony @JTBrennan8 @AwkwardPancake @clkormendy @ErinBrockovich Unless you can read this, and understand 100% of it. There is no need for you to have this condescending conversation with medical professionals. https://t.co/PLYqQ9PROX
RT @AdamJKucharski: Lots of coverage of this case study of symptomatic reinfection with SARS-CoV-2 after short period of time in US (https:…
@Musicaypaz5011 Aunque se desconoce su frecuencia y por suerte parece ser baja, es una realidad la reinfección. https://t.co/7mVfBy8efV
RT @AdamJKucharski: Lots of coverage of this case study of symptomatic reinfection with SARS-CoV-2 after short period of time in US (https:…
A compelling case story on #Covid19 #Variants and reinfection https://t.co/d4aFthQ9D1 @justgeorgeous2 @cbcnewsbc @CBCNews @RachelNotley @jjhorgan
@1971simon @CDCofBC And this compelling case on reinfection... https://t.co/d4aFthQ9D1
Genomic evidence for reinfection with SARS-CoV-2: a case study https://t.co/4OOd6Saf8p
As reinfecções podem ser relevantes para o desenvolvimento de vacinas, pois o vírus apresenta diversas modificações e conseguimos obter os anticorpos produzidos pelo sistema imunológico após infecção. Referência: https://t.co/3RYS88b8ZT
@ZubyMusic 2/ Article by the Lancet arguing this https://t.co/v6P7omkCbR
RT @DataDrivenMD: In case anyone is curious: the first *confirmed* US-based reinfection was reported in mid-October 2020. At that time, th…
RT @DataDrivenMD: In case anyone is curious: the first *confirmed* US-based reinfection was reported in mid-October 2020. At that time, th…
In case anyone is curious: the first *confirmed* US-based reinfection was reported in mid-October 2020. At that time, there were 3-4 other confirmed reinfections worldwide.
@dukejamdogmom The first U.S. case of reinfection that the scientific community acknowledges was reported on October 12, 2020: https://t.co/fENQq3x69E original article: https://t.co/kg88SI9sEP
Sars 222 https://t.co/sZp6dv1S5t
These findings suggest that the patient was infected by SARS-CoV-2 on two separate occasions by a genetically distinct virus. https://t.co/vDPjVUnGGK
RT @GidMK: 31/n Fact 31: COVID-19 reinfections occur. While we do not know the exact rate as of yet, and it may be very low, as time goes o…
@CityCynthia @CityNews Identified SARS-Cov-2 variants at the time this genomic study of reinfection was published. Infection and reinfection genomic variants labelled as Specimens A and B, respectively. https://t.co/6reNDfYxcc https://t.co/lFf172yIVa
@BerrierMona @shannonrwatts People can be infected more than once. There's a large re-infection rate in Manaus & South Africa. https://t.co/6nK5VKm7UR
@myartsells @mostsmartest @StephanieJean78 @BerrierMona @shannonrwatts Those who have been re-infected often develop more severe symptoms from the re-infection. https://t.co/6nK5VKm7UR
@shannonrwatts It is possible that he might be reinfected. There are documented cases of this, but it is rare. He should get the PCR test to confirm. Here is one example of reinfection. https://t.co/5wlmHLKVNJ
RT @EllaKuhn7: @RYP__ 37 results for "sars cov2 reinfection review" on pubmed. here's one from US similar to what you're describing. 2nd c…
RT @EllaKuhn7: @RYP__ 37 results for "sars cov2 reinfection review" on pubmed. here's one from US similar to what you're describing. 2nd c…
@RYP__ 37 results for "sars cov2 reinfection review" on pubmed. here's one from US similar to what you're describing. 2nd case was more severe. Genomic evidence for reinfection with SARS-CoV-2: a case study https://t.co/iqQ1bN1JUD
@omlazo @laprofegatuna https://t.co/a24hqnSaEs https://t.co/Vw64f2AKeP basicamente porque no se sabe que una vez infectado por cuanto tiempo dura la inmunidad. Adjunto comentario de lancet y ek caso estudio de reeinfection y el consejo de la cdc https://t.
@skarlamangla LACDPH R0 calc assumes immunity from reinfection. This is a Lancet article that cautions against that assumption: https://t.co/05mC11x8Zk
Lancet article here https://t.co/05mC11x8Zk
8/A For instance, a classical model assumes that after infection, one's immune system makes one permanently immune to re-infection. That's wrong (ex: antibody levels eventually fall too low). https://t.co/ECEKWeYa1x https://t.co/9kKg1buNHS https://t.c
@markwbudde The phase III studies for the vaccines did not include people who already got #COVID19, so I cannot comment on that part. We don’t know exactly why reinfection happens in every case, but people have been infected with different variants htt
@Kyc_sapa @LauroGarza @DamarisFany Y un bonus de The Lancet https://t.co/4Scb0WfrwK
@APK_musicreview @itsbridgerp @Peston @neil_ferguson @CebmOxford Reason is that it requires sequencing of the original second infection to prove reinfection. Sequencing early on was rare, even now only 10% of UK cases are sequenced. If infection levels in
@0Schneewitchen Hat man nie gesagt, hat man kurze Zeit im Frühjahr gehofft. Bei manchen Leuten ist es wohl so. Es ist auch schon klar, dass bei manchen Leuten die zweite Infektion schlimmer läuft als die erste. https://t.co/LO6qInYukM https://t.co/rYKm1T
@HenryFo25102619 @beefyfarmer @DrHoenderkamp No-one apart from: https://t.co/I0zboJLMAt https://t.co/OZCvJsaiJA
@javelinsam @JuliaHB1 As I said clickbait https://t.co/LqW4c4oCUb
@EdwardTHardy A case study shows it’s possible to get COVID twice.
@markepsom @mattuthompson Just in case you are genuinely interested, The Lancet on reinfection https://t.co/yJ3ravj490
@JuliaHB1 “Genetic discordance of the two SARS-CoV-2 specimens was greater than could be accounted for by short-term in vivo evolution. These findings suggest that the patient was infected by SARS-CoV-2 on two separate occasions by a genetically distinct v
@Wezaxx @VojtechGibis Problém je trvanlivost imunity. Stejně jako je loterií samotné nakažení, obtížnost průběhu a možné trvalé následky, je loterií i imunita vůči reinfekci. Existuje Paper, který popisuje reinfekci v podstatě za měsíc, navíc s horším průb
The first infection might make your body developing the antibodies. But if you get reinfection, meaning the virus is more virulent than the first infection. Hence,, more dangerous. I managed to read this one for now. Nanti i cari again more researchs http
@elchi2man Non pour les rapports de cas https://t.co/KuZRPuQQYK Pour SIREN, je ne sais pas
and this one @EliasVisontay @tegangeorge @latikambourke https://t.co/u5RW0ym4Va